Locations
Conditions
Treatments
Institutions
Resources
For researchers
About us
Clinical trials
DNAJB1-PRKACA Fusion Kinase Peptide Vaccine Combined With Nivolumab and Ipilimumab for Patients With Fibrolamellar Hepatocellular Carcinoma
Apply
DNAJB1-PRKACA Fusion Vaccine, Nivolumab & Ipilimumab
DNAJB1-PRKACA Fusion Kinase Peptide Vaccine Combined With Nivolumab and Ipilimumab for Patients With Fibrolamellar Hepatocellular Carcinoma
Basic information
Step 1/5
Provide your basic information
Age
ZIP code
Back
Next step